NO20030762D0 - Improved specificity in the treatment of diseases - Google Patents

Improved specificity in the treatment of diseases

Info

Publication number
NO20030762D0
NO20030762D0 NO20030762A NO20030762A NO20030762D0 NO 20030762 D0 NO20030762 D0 NO 20030762D0 NO 20030762 A NO20030762 A NO 20030762A NO 20030762 A NO20030762 A NO 20030762A NO 20030762 D0 NO20030762 D0 NO 20030762D0
Authority
NO
Norway
Prior art keywords
diseases
treatment
improved specificity
specificity
improved
Prior art date
Application number
NO20030762A
Other languages
Norwegian (no)
Other versions
NO20030762L (en
Inventor
Johnson Lau
Zhi Hong
Chin-Chung Lin
Original Assignee
Ribapharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribapharm Inc filed Critical Ribapharm Inc
Publication of NO20030762D0 publication Critical patent/NO20030762D0/en
Publication of NO20030762L publication Critical patent/NO20030762L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
NO20030762A 2000-08-22 2003-02-18 Improved specificity in the treatment of diseases NO20030762L (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22687000P 2000-08-22 2000-08-22
US22687100P 2000-08-22 2000-08-22
US22694800P 2000-08-22 2000-08-22
PCT/US2000/033454 WO2002016382A1 (en) 2000-08-22 2000-12-07 Improved specificity in treatment of diseases

Publications (2)

Publication Number Publication Date
NO20030762D0 true NO20030762D0 (en) 2003-02-18
NO20030762L NO20030762L (en) 2003-04-22

Family

ID=27397667

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030762A NO20030762L (en) 2000-08-22 2003-02-18 Improved specificity in the treatment of diseases

Country Status (15)

Country Link
EP (1) EP1351966A1 (en)
JP (1) JP2004518618A (en)
KR (1) KR20030040415A (en)
CN (1) CN1460109A (en)
AU (1) AU2001220806A1 (en)
BR (1) BR0017318A (en)
CA (1) CA2416748A1 (en)
CZ (1) CZ2003460A3 (en)
HU (1) HUP0302882A3 (en)
IL (1) IL154168A0 (en)
MX (1) MXPA03001528A (en)
NO (1) NO20030762L (en)
PL (1) PL365879A1 (en)
TW (1) TW200414903A (en)
WO (1) WO2002016382A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2181704B1 (en) 2002-12-30 2015-05-06 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
CN100448879C (en) * 2004-07-22 2009-01-07 北京化工大学 Method for preparing unformed cefuroxime axetil

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991078A (en) * 1971-06-01 1976-11-09 Icn Pharmaceuticals, Inc. N-substituted 1,2,4-triazoles
US3984396A (en) * 1971-06-01 1976-10-05 Icn Pharmaceuticals, Inc. 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides
USRE29835E (en) * 1971-06-01 1978-11-14 Icn Pharmaceuticals 1,2,4-Triazole nucleosides
US4093624A (en) * 1977-01-31 1978-06-06 Icn Pharmaceuticals, Inc. 1,2,4-Thiadiazolidine-3,5-dione
JPS6426593A (en) * 1987-07-21 1989-01-27 Asahi Glass Co Ltd Nucleoside derivative
US4925930A (en) * 1988-11-02 1990-05-15 Nucleic Acid Research Institute Synthesis and anti-leukemic activity of alkyl-1-(β-D-ribofuranosyl)[1,2,4]triazole-3-carboximidates

Also Published As

Publication number Publication date
AU2001220806A1 (en) 2002-03-04
TW200414903A (en) 2004-08-16
CZ2003460A3 (en) 2003-10-15
BR0017318A (en) 2004-06-15
KR20030040415A (en) 2003-05-22
WO2002016382A1 (en) 2002-02-28
CN1460109A (en) 2003-12-03
NO20030762L (en) 2003-04-22
CA2416748A1 (en) 2002-02-28
MXPA03001528A (en) 2004-04-02
EP1351966A1 (en) 2003-10-15
HUP0302882A2 (en) 2003-12-29
HUP0302882A3 (en) 2005-06-28
IL154168A0 (en) 2003-07-31
PL365879A1 (en) 2005-01-10
JP2004518618A (en) 2004-06-24

Similar Documents

Publication Publication Date Title
NO20024273L (en) Therapeutic uses of PPAR mediators
NO20031442L (en) Morpholine-acetamide derivatives for the treatment of inflammatory diseases
DE60124302D1 (en) THIAZONE DERIVATIVES FOR THE TREATMENT OF PPAR-LIFE DISEASES
MXPA03002813A (en) Compounds useful in the treatment of inflammatory diseases.
ATE472325T1 (en) INTRACORPORAL MEDICATIONS FOR THE PHOTODYNAMIC TREATMENT OF DISEASES
EE05507B1 (en) Use of rosuvastatin ZD4522) in the treatment of heterosgococcal family h percolesterolemia
NO20026008L (en) Procedure for the treatment of cardiovascular diseases
NO20024775D0 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20032122D0 (en) Improved treatment
NO20024486L (en) Improved treatment of neovascularization
ID27576A (en) USE OF CYCOSPORINE IN TREATMENT OF AUTOIMUN DISEASE DISEASES
DE50013843D1 (en) MEDICAMENT FOR THE TREATMENT OF DARMER DISEASES
NO20024777L (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20024776L (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
DE60016047D1 (en) DIHYDROBENZOPYRANE, DIHYDROBENZOTHIOPYRANE AND TETRAHYDROCHINOLINE FOR THE TREATMENT OF COX-2-DEPENDENT DISEASES
NO20024236D0 (en) Treatment of psoriasis
DE60103685D1 (en) Treatment of poriomania
NO20023803L (en) Use of mirtazapine for the treatment of sleep disorders
NO20030762L (en) Improved specificity in the treatment of diseases
NO20012612L (en) Isonipecotamides for the treatment of integrin-mediated diseases
ID30458A (en) OSANETAN IN TREATMENT OF SOUL DISORDERS
NO20030767L (en) Treatment of burns
EE200300013A (en) Novel bispidine compounds and their use in the treatment of cardiac arrhythmias
DE60125035D1 (en) TREATMENT OF PLASMID-CONTAINING SOLUTIONS
NO20023243D0 (en) New therapeutic use of enoxaparin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application